Since RCAS1 promotes tumor cell evasion of immune surveillance by inducing apoptosis in immune cells, including peripheral lymphocytes, and also remodels the cancer stromal microenvironment, RCAS1 is believed to contribute to tumor progression [2]. This evidence concerns the gene EBAG9 and neoplasm.